Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Neos Therapeutics, Inc. (NEOS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Net product sales  64.650.027.110.03.8  
Total revenues   [+]64.650.027.110.03.80.81.0
            Revenue growth   [+]29.3%84.2%170.4%164.6%400.3%-27.4% 
Cost of goods sold  25.126.914.011.75.93.42.5
Gross profit  39.523.113.1-1.7-2.1-2.6-1.5
            Gross margin  61.1%46.1%48.3%-17.0%-56.4%-347.4%-142.7%
Selling, general and administrative   [+]41.458.060.761.912.85.35.6
Research and development  8.68.59.012.211.710.610.0
Other operating expenses  1.0-0.2     
EBITDA   [+]-9.3-41.5-55.2-72.6-23.3-15.8-14.9
            EBITDA margin  -14.4%-83.1%-203.4%-723.3%-615.4%-2079.0%-1428.7%
Depreciation  0.30.0-0.31.61.71.61.3
EBITA  -9.6-41.5-54.9-74.2-25.1-17.4-16.2
            EBITA margin  -14.9%-83.1%-202.3%-739.2%-660.9%-2296.0%-1556.1%
Amortization of intangibles  1.71.71.71.71.51.10.8
EBIT   [+]-11.4-43.3-56.5-75.8-26.6-18.5-17.1
            EBIT margin  -17.6%-86.6%-208.4%-755.7%-700.9%-2436.9%-1636.8%
Non-recurring items  -1.00.2     
Interest expense  8.09.010.16.93.72.52.1
Other income (expense), net   [+]1.50.80.90.0-0.50.10.6
Pre-tax income  -16.9-51.7-65.8-82.8-30.8-20.8-18.6
Income taxes  0.00.00.00.00.00.00.4
            Tax rate   0.0%0.0%0.0%0.0%0.0% 
Net income  -16.9-51.7-65.8-82.8-33.2-24.2-22.4
            Net margin  -26.1%-103.4%-242.4%-824.8%-874.8%-3186.3%-2150.3%
   
Basic EPS   [+]($0.34)($1.60)($2.66)($5.16)($4.38)($27.56)($28.45)
Diluted EPS   [+]($0.34)($1.60)($2.66)($5.16)($4.38)($27.56)($28.45)
   
Shares outstanding (basic)   [+]49.732.324.816.17.60.90.8
Shares outstanding (diluted)   [+]49.732.324.816.17.60.90.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy